Product code KLI— Clinical Chemistry

CEDIA T4 MAB ASSAY

Classification name
Enzyme Immunoassay, Non-Radiolabeled, Total Thyroxine
Device class
Class 2
Regulation
21 CFR 862.1700
Advisory panel
Clinical Chemistry
Total cleared
86
First cleared
Most recent

Market context for product code KLI

FDA has cleared 86 devices under product code KLI between 1977 and 2016, filed by 55 applicant companies. No FDA device recalls reference this product code. Class II devices are moderate-risk and subject to general and special controls; most reach market through 510(k) clearance by demonstrating substantial equivalence to a predicate device.

Clearances per year

last 15 years

Top applicants under product code KLI

Recent clearances under product code KLI

Data sourced from openFDA. This site is unofficial and independent of the FDA.